دورية أكاديمية
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries.
| العنوان: | Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries. |
|---|---|
| المؤلفون: | Arsenault C; Department of Global Health, Milken Institute School of Public Health, The George Washington University, Washington DC, USA. Electronic address: catherine.arsenault@gwu.edu., Lewis TP; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA., Kapoor NR; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA., Okiro EA; Population & Health Impact Surveillance Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya., Leslie HH; Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Armeni P; CERGAS SDA Bocconi School of Management, Bocconi University, Milan, Italy., Jarhyan P; Public Health Foundation of India, Gurgaon, Haryana, India., Doubova SV; Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico., Wright KD; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA., Aryal A; Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland., Kounnavong S; Lao Public Health Association, Ministry of Health, Vientiane, Laos., Mohan S; Public Health Foundation of India, Gurgaon, Haryana, India., Odipo E; Population & Health Impact Surveillance Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya., Lee HY; Graduate School of Public Health and Healthcare Management, The Catholic University of Korea, Seoul, South Korea., Shin J; Department of Medicine, Seoul National University College of Medicine, Seoul, South Korea., Ayele W; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia., Medina-Ranilla J; Faculty of Public Health and Administration, Epidemiology Department, Universidad Peruana Cayetano Heredia, Lima, Peru., Espinoza-Pajuelo L; Faculty of Public Health and Administration, Epidemiology Department, Universidad Peruana Cayetano Heredia, Lima, Peru., Derseh Mebratie A; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia., García Elorrio E; Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina., Mazzoni A; Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina., Oh J; Department of Medicine, Seoul National University College of Medicine, Seoul, South Korea., SteelFisher GK; Department of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA, USA., Tarricone R; CERGAS SDA Bocconi School of Management, Bocconi University, Milan, Italy., Kruk ME; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA. |
| المصدر: | The Lancet. Global health [Lancet Glob Health] 2024 Jan; Vol. 12 (1), pp. e156-e165. Date of Electronic Publication: 2023 Dec 11. |
| نوع المنشور: | Meta-Analysis; Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [England] : Elsevier Ltd. 2013- |
| مواضيع طبية MeSH: | COVID-19*/epidemiology , COVID-19*/prevention & control , Vaccines*, Humans ; Cross-Sectional Studies ; COVID-19 Vaccines ; Vaccination |
| مستخلص: | The social and behavioural determinants of COVID-19 vaccination have been described previously. However, little is known about how vaccinated people use and rate their health system. We used surveys conducted in 14 countries to study the health system correlates of COVID-19 vaccination. Country-specific logistic regression models were adjusted for respondent age, education, income, chronic illness, history of COVID-19, urban residence, and minority ethnic, racial, or linguistic group. Estimates were summarised across countries using random effects meta-analysis. Vaccination coverage with at least two or three doses ranged from 29% in India to 85% in Peru. Greater health-care use, having a regular and high-quality provider, and receiving other preventive health services were positively associated with vaccination. Confidence in the health system and government also increased the odds of vaccination. By contrast, having unmet health-care needs or experiencing discrimination or a medical mistake decreased the odds of vaccination. Associations between health system predictors and vaccination tended to be stronger in high-income countries and in countries with the most COVID-19-related deaths. Access to quality health systems might affect vaccine decisions. Building strong primary care systems and ensuring a baseline level of quality that is affordable for all should be central to pandemic preparedness strategies. Competing Interests: Declaration of interests Research for this Series paper was supported by grants to MEK and the QuEST Network from the Bill & Melinda Gates Foundation and the Swiss Federal Department of Foreign Affairs. This research was also supported by grants to CA and MEK from Merck Sharp & Dohme; to EGE and HHL from the Inter-American Development Bank; and to JO from the Taejae Foundation. The funders of the study had no role in study design or conduct, data collection, data management, data analysis, data interpretation, the writing of the Series paper, or the decision to submit the Series paper for publication. (Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.) |
| References: | Lancet Infect Dis. 2021 Jul;21(7):922-923. (PMID: 34174236) Health Aff (Millwood). 2013 Feb;32(2):207-14. (PMID: 23381511) Lancet Public Health. 2021 Jun;6(6):e416-e427. (PMID: 33991482) Nat Med. 2021 Aug;27(8):1385-1394. (PMID: 34272499) N Engl J Med. 2022 Mar 31;386(13):1278-1279. (PMID: 35353966) PLoS One. 2017 Dec 18;12(12):e0189900. (PMID: 29253855) Nat Med. 2021 Feb;27(2):225-228. (PMID: 33082575) Pediatrics. 2007 Feb;119 Suppl 1:S4-11. (PMID: 17272584) PLoS One. 2017 Apr 18;12(4):e0175534. (PMID: 28419106) Lancet Reg Health Am. 2023 Feb;18:100409. (PMID: 36536782) Med Care. 1999 Jun;37(6):547-55. (PMID: 10386567) Am J Public Health. 2000 Jun;90(6):962-5. (PMID: 10846516) Vaccine. 2023 Apr 6;41(15):2572-2581. (PMID: 36907734) N Engl J Med. 2022 Jul 7;387(1):58-65. (PMID: 35767527) Nat Hum Behav. 2022 Dec;6(12):1615-1624. (PMID: 35654962) PLoS Med. 2019 Aug 7;16(8):e1002879. (PMID: 31390364) Health Serv Res. 2005 Apr;40(2):389-400. (PMID: 15762898) Lancet. 2023 Mar 18;401(10380):967-970. (PMID: 36871571) Commun Med (Lond). 2021 Sep 9;1:30. (PMID: 35602227) Nat Med. 2023 Feb;29(2):366-375. (PMID: 36624316) JAMA Netw Open. 2022 Jan 4;5(1):e2144470. (PMID: 35061038) Hosp Top. 2015;93(3):60-8. (PMID: 26652042) Z Gesundh Wiss. 2022 Sep 19;:1-17. (PMID: 36160668) Am J Infect Control. 2022 Oct;50(10):1185-1189. (PMID: 35688229) Lancet Glob Health. 2018 Nov;6(11):e1196-e1252. (PMID: 30196093) Vaccine. 2012 May 21;30(24):3546-56. (PMID: 22480928) Nat Med. 2022 Jun;28(6):1314-1324. (PMID: 35288697) JAMA Netw Open. 2021 Sep 1;4(9):e2126882. (PMID: 34559232) NPJ Vaccines. 2021 Sep 30;6(1):118. (PMID: 34593822) Lancet Public Health. 2021 Apr;6(4):e210-e221. (PMID: 33556325) |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) 0 (Vaccines) |
| تواريخ الأحداث: | Date Created: 20231214 Date Completed: 20231216 Latest Revision: 20231216 |
| رمز التحديث: | 20231217 |
| مُعرف محوري في PubMed: | PMC10716622 |
| DOI: | 10.1016/S2214-109X(23)00490-4 |
| PMID: | 38096888 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder كن أول من يترك تعليقا!